Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Whether to determine HER2 status for breast cancer in the primary tumour or in the metastasis.
2009
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
2013
Breast cancer
2019 Standout
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
2010
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
2009
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
2000
New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available
2011
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Platinum-based chemotherapy in metastatic breast cancer: current status
2003
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma
2010
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
2010 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk
2014
Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
2009
Serum Uric Acid and Cardiovascular Mortality
2000 Standout
Cardioncology: State of the heart
2013
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
2010
Current Strategies in Whole-brain Radiation Therapy for Brain Metastases
2005
Liposome: classification, preparation, and applications
2013 Standout
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers
2004
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
2014
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
2010
Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective
2017
Interferon-α and cancer: Mechanisms of action and new perspectives of clinical use
2007
Cancer treatment and survivorship statistics, 2012
2012 Standout
Phase I Study of Nonpegylated Liposomal Doxorubicin plus Trastuzumab in Patients with HER2-Positive Breast Cancer
2009
Cardiovascular Complications of Cancer Therapy
2009
Management of brain metastases
2004
Current and future developments in the use of temozolomide for the treatment of brain tumours
2001
Platinum Compounds in the Treatment of Advanced Breast Cancer
2001
New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the seventh world conference on lung cancer
1995
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
2013
Cisplatin: The first metal based anticancer drug
2019 Standout
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review
2010
Factors affecting the prognosis of breast cancer patients with brain metastases
2008
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
2014
Interferon-alpha in tumor immunity and immunotherapy
2002
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer
2007
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
2015
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Transgender Medicare Beneficiaries and Chronic Conditions: Exploring Fee-for-Service Claims Data
2017 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
Fluoropyrimidine-associated cardiotoxicity: revisited
2009
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
1999 Standout
Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells
2020
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
2006
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Breast Cancer Treatment
2019 Standout
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
2009
Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study
2004
Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review
2009
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
2011
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
2011 StandoutNobel
Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma
2003
Trends in the Aggressiveness of Cancer Care Near the End of Life
2004 Standout
Hyperuricemia in coronary, cerebral and peripheral arterial disease: An explanation
1975
Medical Management of Brain Metastases and Leptomeningeal Disease in Patients with Breast Carcinoma
2018
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
CNS Metastases in Breast Cancer
2004
Works of A. Karabelis being referenced
HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.
2006
A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer
2005
Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index
1998
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
2001
First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer
1993
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study
2007
A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens
2006
The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b.
1992
Cisplatin/ifosfamide/vinblastine (VIP) vs, cisplatin/ifosfamide etoposide (VIR-16) in non-small cell lung cancer (NSCLC). A prospective randomized phase III study
1994
Paclitaxel (P), pegylated liposomal doxorubicin (PLD) and trastuzumab as 1st-line chemotherapy (chemo) in HER2/neu-positive (+) metastatic breast cancer (MBC)
2006
A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer
1992
Temozolomide in Combination With Docetaxel in Patients With Advanced Melanoma: A Phase II Study of the Hellenic Cooperative Oncology Group
2002
Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II study.
2003
Hyperuricemia in Patients With Peripheral Arterial Occlusive Disease
1974